Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?

Saved in:
Bibliographic Details
Title: Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?
Authors: Boddington NL; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK., Elgohari S; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK., Ellis J; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK., Donati M; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK.; South West Regional Laboratory and Severn Infection Sciences, North Bristol NHS Trust, Bristol, UK., Zambon M; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK., Pebody RG; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK.; Reference Microbiology Services, WHO Regional Office for Europe, Copenhagen, Denmark.
Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Sep; Vol. 16 (5), pp. 937-941. Date of Electronic Publication: 2022 May 18.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1750-2659
DOI:10.1111/irv.13001